Advestra with Sandoz on CHF 550 m bonds issuance

Advestra advised Sandoz, a generic and biosimilar medicines specialist with headquarters in Basel, on its CHF 550 million bonds issuance.

The issuance comprises a CHF 275 million tranche with a six-year maturity and a 1.1875% coupon, and a CHF 275 million tranche with a 10-year maturity and a 1.55% coupon. The proceeds will be used for general corporate purposes, including the refinancing of maturing debt.

The Advestra team

The Advestra team working on the matter included Annette Weber (pictured) and Jan-Nicklas Bentz (both capital markets), as well as Céline Martin (tax).